Last $31.22 USD
Change Today -0.48 / -1.51%
Volume 2.5M
ACAD On Other Exchanges
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Glenn F. Baity

Vice President, General Counsel, Corporate Compliance Officer and Secretary, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Glenn F. Baity serves as Vice President, General Counsel, Corporate Compliance Officer and Secretary at ACADIA Pharmaceuticals, Inc. Mr. Baity has been with ACADIA Pharmaceuticals since July 2004. From February 2000 to July 2004, Mr. Baity served as a Senior Associate at Cooley Godward Kronish, LLP in their San Diego office, working with a variety of public and private companies on transactional matters, including M&A, financings, compensation and equity matters, ...

Read Full Background

Corporate Headquarters*

11085 Torreyana Road
San Diego, California 92121

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

There is no Board Members Memberships data available.


University of California
University of California

Other Affiliations*

Annual Compensation*

Total Annual Compensation$445,000

Stock Options*

All Other Compensation$13,689
Exercised Options120,000
Exercised Options Value$1,307,400
Exercisable Options286,875
Unexercisable Options253,125
Total Value of Options$1,307,400
Total Number of Options660,000

Total Compensation*

Total Annual Cash Compensation$458,689
Total Short Term Compensation$445,000
Other Long Term Compensation$13,689
Total Calculated Compensation$2,135,767
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $31.22 USD -0.48


Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at